After three very successful editions (Jan 2015, Leuven, March 2017, Antwerp and March 2019, Antwerp), VIB is proud to present the fourth edition of this Tools & Technologies conference.
Next generation sequencing has been and is still revolutionizing discoveries across life sciences. While established sequencing technologies are now fully embedded in the clinic and diagnostic settings, novel technological advancements spur the next revolution in sequencing technologies. These will open new avenues for research and enable new genomics insights not possible before. This conference aims to bring together experts in both established and novel sequencing technologies along with top scientists in the field.
Over the past decade, technological advances that enable the characterization of single cells at the molecular level rather than in bulk tissues have led to significant breakthrough discoveries with revolutionary insights in diseases, such as cancer, inflammatory and neurodegenerative diseases. Therefore, specific focus of this conference will be on advances in single cell sequencing, ranging from transcriptomics, genomics, proteomics to combined multi-omics analysis at the single cell level. On top, with spatial context of cells becoming increasingly important to unravel cell functioning and behavior, a dedicated session will focus on technological advancements in spatial sequencing and breakthrough scientific discoveries that these have enabled.
This exciting conference puts together an excellent program including renowned leaders in the field that will cover the following topics:
- Long reads & genome structure
- Single cell sequencing
- Spatial sequencing technologies
- Population scale and clinical sequencing
- Technology trends
In addition to a great scientific and technology program, the conference will provide many opportunities to network during the breaks, poster sessions and much more!
- Manolis Kellis, MIT Computer Science and Artificial Intelligence Lab; Broad Institute of MIT and Harvard, US
- Radoje (Rade) Drmanac, CSO, MGI, CN
- Siyu (Sisi) Chen, California Institute of Technology, US
- Sara Goodwin, Cold Spring Harbor Laboratory, US
- Charlie Silver, CEO Mission Bio, US
- Christopher Mason, Weill Cornell Medicine, US
and many more